Avenue Capital Group is a global investment firm focused on distressed, and undervalued debt and equity opportunities across the world.
Business Model:
Revenue: $21.3M
Employees: 51-200
Address: 11 West 42nd Street
City: New York
State: NY
Zip: 10036
Country: US
Avenue Capital Group was founded in 1995 by Marc Lasry and Sonia E. Gardner. Pioneers in the distressed debt market, Mr. Lasry and Ms. Gardner have successfully invested in the public and private debt and equity securities of distressed companies across a variety of industries for over two decades. Headquartered in New York, with offices in London, Luxembourg, Munich, and nine offices throughout Asia, the firm manages assets valued at approximately $15.8 billion as of March 31, 2009. Avenue draws on the skills and experience of approximately 300 employees and its Senior Principals, Marc Lasry and Sonia E. Gardner, who have spent virtually their entire careers in the field of distressed investments.
Contact Phone:
+12128507500
Contact Email:
Listed Exchange:
NYSE
IPO Date:
2/4/2011
Ticker Symbol:
ACP
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2021 | Netomnia | Debt Financing | 0 |
11/2018 | Asset Reconstruction Company (India) Ltd. | Secondary Market | - |
10/2022 | Kin Insurance | Debt Financing | 0 |
10/2008 | Ambow Education Group | Series C | 103M |
12/2021 | Intellihot | Venture Round | 0 |
9/2020 | Zorin Finance | Debt Financing | 256.4M |
11/2022 | Eyenovia | Post-IPO Debt | 10M |
8/2021 | Delcath Systems | Post-IPO Debt | 20M |
4/2021 | Third Pole | Debt Financing | 0 |
6/2008 | Wuxi Qiaolian Wind Power Technology | Series A | 0 |
8/2022 | Oliver Space | Series B | 0 |
4/2022 | Enerkem | Debt Financing | 0 |
7/2021 | Cytocom | Post-IPO Debt | 0 |
10/2007 | Ambow Education Group | Series B | 54M |
8/2019 | Castlehaven Finance | Private Equity Round | 0 |
12/2021 | BioVie | Post-IPO Debt | 15M |
1/2022 | Aytu BioScience | Post-IPO Debt | 15M |
4/2022 | Enerkem | Debt Financing | 0 |
1/2022 | Aytu BioScience | Post-IPO Debt | 0 |
12/2021 | Intellihot | Venture Round | 0 |
12/2021 | BioVie | Post-IPO Debt | 0 |
11/2021 | Netomnia | Debt Financing | 0 |
8/2021 | Delcath Systems | Post-IPO Debt | 0 |
7/2021 | Cytocom | Post-IPO Debt | 0 |
4/2021 | Third Pole | Debt Financing | 0 |
9/2020 | Zorin Finance | Debt Financing | 0 |
8/2019 | Castlehaven Finance | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|